Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
32 participants
INTERVENTIONAL
2020-11-05
2024-11-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Continuous Glucose Monitoring in Adolescents With Poorly Controlled Type 1 Diabetes
NCT01586065
SUPPORT Online Training Platform for Type 1 Diabetes Self-management Education and Support (SUPPORT)
NCT04233138
A Pilot Study to Evaluate the Safety of Terbutaline in Children With Type 1 Diabetes
NCT00607503
Web-Based Simulation Tool For Self-Management Support In Type 1 Diabetes Mellitus
NCT04439903
Hypoglycemia at Initiation of Pump Therapy in Children With Type 1 Diabetes
NCT01840358
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Your child's doctor/NP will be able to remotely monitor your child's glucose every week (Dexcom) and make recommendations for changes, discuss solutions to possible obstacles and offer intensive diabetes education.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
standard of care
standard of care will be given as per usual care
telehealth visits
intensive visits with doctor
intensive monitoring
intensive monitoring every week will be given to participants
telehealth visits
intensive visits with doctor
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
telehealth visits
intensive visits with doctor
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. HbA1c \> 8.5%
3. Duration of type 1 diabetes \>1 year
4. Child uses Dexcom and has a phone that is compatible with the InPen app and Dexcom Clarity app.
Exclusion Criteria
11 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Georgetown University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medstar Pediatrics
Washington D.C., District of Columbia, United States
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2604
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.